Oculis Holding AG (OCS) EBIT (2022 - 2026)
Quarterly EBIT fell 15.8% to $266894.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.1 million through Mar 2026, up 85.38% year-over-year, with the annual reading at $1.5 million for FY2025, 91.57% up from the prior year.
Oculis Holding AG's EBIT history spans 5 years, with the latest figure at $266894.0 for Q1 2026.
- EBIT came in at $266894.0 for Q1 2026, down from $514230.8 in the prior quarter.
- In the past five years, EBIT ranged from a high of $514230.8 in Q4 2025 to a low of $249.31 in Q3 2024.
- The 5-year median for EBIT is $248565.9 (2023), against an average of $225327.2.
- Year-over-year, EBIT tumbled 99.9% in 2024 and then surged 14915.94% in 2025.
- Oculis Holding AG's EBIT stood at $222136.7 in 2022, then decreased by 6.11% to $208560.6 in 2023, then crashed by 98.36% to $3424.6 in 2024, then soared by 14915.94% to $514230.8 in 2025, then tumbled by 48.1% to $266894.0 in 2026.
- Per Business Quant, the three most recent readings for OCS's EBIT are $266894.0 (Q1 2026), $514230.8 (Q4 2025), and $303.78 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -2.97 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | -19.70 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -15.76 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 1.14 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 642.90 Mn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | -3.82 Mn |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 268.64 Mn |
| 10 | Oculis Holding AG | 24.51 Bn | 24.21 Bn | - | 266,893.98 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 266,893.98 |
| Dec 31, 2025 | 514,230.78 |
| Sep 30, 2025 | 303.78 |
| Jun 30, 2025 | 315,259.35 |
| Mar 31, 2025 | 316,991.40 |
| Dec 31, 2024 | 3,424.57 |
| Sep 30, 2024 | 249.31 |
| Jun 30, 2024 | 270,919.40 |
| Mar 31, 2024 | 254,341.47 |
| Dec 31, 2023 | 208,560.58 |
| Sep 30, 2023 | 247,941.41 |
| Jun 30, 2023 | 278,043.89 |
| Mar 31, 2023 | 247,586.23 |
| Dec 31, 2022 | 222,136.69 |
| Sep 30, 2022 | 209,162.24 |
| Jun 30, 2022 | 249,190.32 |